FCGR2A and dilated cardiomyopathy: However, compared with IFN-γ-only treatment, GSKJ1 treatment attenuated the IFN-γ-induced upregulation of genes involved in FcγR-mediated phagocytosis, dilated cardiomyopathy and extracellular matrix receptor interaction (Fig. 3c).